Atlas Trials

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Clinical trial NCT06831552 · RECRUITING

Trial details

NCT number
NCT06831552
Sponsor
Dana-Farber Cancer Institute
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
NeuroblastomaHigh-risk Neuroblastoma
Start date
2025-04-30
Primary completion
2029-06-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.